Nan Fung Group Holdings LTD Vir Biotechnology, Inc. Transaction History

Nan Fung Group Holdings LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$19.08 - $26.7 $4.02 Million - $5.62 Million	-210,563 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$30.97 - $54.03 $1.56 Million - $2.72 Million	50,352 Added 31.43%	210,563 $8.82 Million
Q3 2021 Nov 15, 2021	BUY	$34.9 - $54.54 $3.2 Million - $4.99 Million	91,548 Added 133.33%	160,211 $6.97 Million
Q2 2021 Sep 22, 2021	BUY	$38.75 - $51.0 $2.66 Million - $3.5 Million	68,663 New	68,663 $3.25 Million

219

87.4M

127K

1.19M

Ticker VIR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 132,638,000
Market Cap $922M
Description
Vir Biotechnology, Inc., a commercial-stage immunology company, develops therapeutic products to treat and prevent serious infectious diseases. It develops Sotrovimab (VIR-7832), a SARS-CoV-2-neutralizing mAbs to treat and prevent COVID-19 infection under the Xevudy brand; VIR-2218 and VIR-3434 for the treatment of hepatitis B virus; VIR-2482 fo...

Get notified when there are updates to the investment portfolio of Nan Fung Group Holdings LTD, based on Form 13F filings with the SEC.

Stay updated on Nan Fung Group Holdings LTD with notifications on news.